84 related articles for article (PubMed ID: 21317921)
1. Cytoplasmic p27 is oncogenic and cooperates with Ras both in vivo and in vitro.
Serres MP; Zlotek-Zlotkiewicz E; Concha C; Gurian-West M; Daburon V; Roberts JM; Besson A
Oncogene; 2011 Jun; 30(25):2846-58. PubMed ID: 21317921
[TBL] [Abstract][Full Text] [Related]
2. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG
Cancer Res; 2006 Sep; 66(17):8529-41. PubMed ID: 16951165
[TBL] [Abstract][Full Text] [Related]
3. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models.
Jackson RJ; Adnane J; Coppola D; Cantor A; Sebti SM; Pledger WJ
Oncogene; 2002 Dec; 21(55):8486-97. PubMed ID: 12466968
[TBL] [Abstract][Full Text] [Related]
4. STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells.
Wang S; Raven JF; Koromilas AE
Mol Cancer Res; 2010 May; 8(5):798-805. PubMed ID: 20407011
[TBL] [Abstract][Full Text] [Related]
5. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
Schepers H; Wierenga AT; Eggen BJ; Vellenga E
Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic p27
Calvayrac O; Nowosad A; Cabantous S; Lin LP; Figarol S; Jeannot P; Serres MP; Callot C; Perchey RT; Creff J; Taranchon-Clermont E; Rouquette I; Favre G; Pradines A; Manenti S; Mazieres J; Lee H; Besson A
J Pathol; 2019 Jan; 247(1):60-71. PubMed ID: 30206932
[TBL] [Abstract][Full Text] [Related]
8. Removal of Cdk inhibitors through both sequestration and downregulation in zearalenone-treated MCF-7 breast cancer cells.
Ahamed S; Foster JS; Bukovsky A; Diehl JA; Wimalasena J
Mol Carcinog; 2002 May; 34(1):45-58. PubMed ID: 12112322
[TBL] [Abstract][Full Text] [Related]
9. Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer.
Timmerbeul I; Garrett-Engele CM; Kossatz U; Chen X; Firpo E; Grünwald V; Kamino K; Wilkens L; Lehmann U; Buer J; Geffers R; Kubicka S; Manns MP; Porter PL; Roberts JM; Malek NP
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14009-14. PubMed ID: 16966613
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
[TBL] [Abstract][Full Text] [Related]
11. Skp2 is oncogenic and overexpressed in human cancers.
Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491
[TBL] [Abstract][Full Text] [Related]
12. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma.
Denicourt C; Saenz CC; Datnow B; Cui XS; Dowdy SF
Cancer Res; 2007 Oct; 67(19):9238-43. PubMed ID: 17909030
[TBL] [Abstract][Full Text] [Related]
13. Loss of p27(Kip1) cooperates with cyclin E in T-cell lymphomagenesis.
Geisen C; Karsunky H; Yücel R; Möröy T
Oncogene; 2003 Mar; 22(11):1724-9. PubMed ID: 12642875
[TBL] [Abstract][Full Text] [Related]
14. Skp2 inversely correlates with p27 and tuberin in transformed cells.
Rosner M; Hanneder M; Siegel N; Valli A; Fuchs C; Hengstschläger M
Amino Acids; 2009 Jul; 37(2):257-62. PubMed ID: 18604603
[TBL] [Abstract][Full Text] [Related]
15. [Expression variation and significance of Skp2 and p27(kip1) during the proliferation of Jurkat cells].
Lu JX; Wang YC; Shen AG; Zhao YM; Sun CL; Zhang DM; Cheng C
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):330-4. PubMed ID: 18953829
[TBL] [Abstract][Full Text] [Related]
16. A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression.
Besson A; Gurian-West M; Chen X; Kelly-Spratt KS; Kemp CJ; Roberts JM
Genes Dev; 2006 Jan; 20(1):47-64. PubMed ID: 16391232
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis.
Philipp J; Vo K; Gurley KE; Seidel K; Kemp CJ
Oncogene; 1999 Aug; 18(33):4689-98. PubMed ID: 10467416
[TBL] [Abstract][Full Text] [Related]
18. The F box protein S phase kinase-associated protein 2 regulates adipose mass and adipocyte number in vivo.
Cooke PS; Holsberger DR; Cimafranca MA; Meling DD; Beals CM; Nakayama K; Nakayama KI; Kiyokawa H
Obesity (Silver Spring); 2007 Jun; 15(6):1400-8. PubMed ID: 17557977
[TBL] [Abstract][Full Text] [Related]
19. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
Auld CA; Fernandes KM; Morrison RF
J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
[TBL] [Abstract][Full Text] [Related]
20. Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype.
Besson A; Hwang HC; Cicero S; Donovan SL; Gurian-West M; Johnson D; Clurman BE; Dyer MA; Roberts JM
Genes Dev; 2007 Jul; 21(14):1731-46. PubMed ID: 17626791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
